Abstract
Chimeric transporters were constructed in which the predicted external loops of the serotonin transporter (SERT) were replaced one at a time with a corresponding sequence from the norepinephrine transporter (NET). All of the chimeric transporters were expressed at levels equal to or greater than those of wild type SERT, but the transport and binding activity of the mutants varied greatly. In particular, mutants in which the NET sequence replaced external loops 4 or 6 of SERT had transport activity 5% or less than that of wild type, and the loop 5 replacement was essentially inactive. In some of these mutants, binding of a high affinity cocaine analog was less affected than transport, suggesting that the mutation had less effect on the initial binding steps in transport than on subsequent conformational changes. The more severely affected mutants also displayed an altered response to Na(+). In contrast to the dramatic reduction in transport and binding, the specificity of ligand binding was essentially unchanged. Chimeric transporters did not gain affinity for dopamine, a NET substrate, or desipramine, an inhibitor, at the expense of affinity for serotonin or paroxetine, a selective SERT inhibitor. The results suggest that external loops are not the primary determinants of substrate and inhibitor binding sites. However, they are not merely passive structures connecting transmembrane segments but rather active elements responsible for maintaining the stability and conformational flexibility of the transporter.
Highlights
The serotonin transporter (SERT)1 is responsible for the accumulation of serotonin (5-hydroxytryptamine, 5-HT) by neurons, platelets, and other cells [1,2,3,4]
In EL2 of SERT, no change in substrate or inhibitor sensitivity was observed when a large portion was replaced with the corresponding sequence from the closely related norepinephrine transporter (NET), the chimeric transporter was severely defective in transport activity [17]
The results suggest that residues responsible for the selectivity of SERT and NET inhibitors are not located in external loops
Summary
(Received for publication, May 20, 1999, and in revised form, September 2, 1999). Yoel Smicun, Scott D. The results suggest that external loops are not the primary determinants of substrate and inhibitor binding sites They are not merely passive structures connecting transmembrane segments but rather active elements responsible for maintaining the stability and conformational flexibility of the transporter. The original topological model for these NaCl-coupled transporters was challenged in studies using mutants of the ␥-aminobutyric acid (GABA) and glycine transporters (GAT-1 and GLYT-1) [10, 11] These studies suggested that the predicted first external loop (EL1) was not exposed on the cell exterior and that the first internal loop (IL1) was extracellular. This study suggested that at least some external loop regions were involved in conformational changes required for transport and did not participate in substrate and inhibitor binding. Many of the mutations exhibited markedly decreased intrinsic transport activity, suggesting that they participated in the conformational changes required for turnover
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.